TORONTO, Canada, April 24, 2019 – Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical applications, will be presenting at The Association for Research in Vision and Ophthalmology 2019 meeting.